A Phase 4 interventional study of Benzidamine hydrochloride and Ketoprofen lysine salt in Pharyngitis, sponsored by Boehringer Ingelheim. Completed. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2014-07-08.
Sponsored by Boehringer Ingelheim · Phase 4, Interventional, and Treatment
A study to in order to verify any differences between the 2 treatment groups in terms of duration of analgesic effects after the first drug intake and time to remission of symptoms and signs of pharyngitis
256 studies on the registry are indexed under Pharyngitis; 36 are open to participants now.
This study's enrollment of 214 is above the median of 143 across 211 interventional studies indexed under Pharyngitis.
Browse Pharyngitis studies →Boehringer Ingelheim is the lead sponsor of 2,297 studies on the registry; 56 are open to participants now.
Of its 166 completed or terminated interventional studies of FDA-regulated products, 121 (73%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Drug: Benzidamine hydrochloride
Drug: Ketoprofen lysine salt
Duration of analgesic effects in hours
Time frame: Up to 6 hours
Average number of days required to obtain remission of pain
day on which 2 consecutive pain measurements are both below 10 mm of the visual analog scale (VAS)
Time frame: Up to day 8
Average severity of edema and hyperemia, assessed by investigator on a 4-point-scale
Time frame: Up to day 8
No study locations are listed for this record.
The record gives a start of Sep 1998 and a primary completion of May 1999. It does not say whether these dates are actual or estimated.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jul 2014. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Ketoprofen lysine